Business
AstraZeneca begins trading on the New York Stock Exchange
WILMINGTON, Del., February 02, 2026--AstraZeneca today begins trading its ordinary shares on the New York Stock Exchange (NYSE) for the first time, enabling more US investors to participate in the Company’s strong growth. With this change the trading of AstraZeneca ordinary shares is now aligned across the NYSE, the London Stock Exchange (LSE) and Nasdaq Stockholm (STO) under a harmonized listing structure.
About this update from Astrazeneca Plc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1438,"height":475,"url":"https://media.zenfs.com/en/business-wire.com/cc51d7b903437bf6121413744e4d5f9c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/RigWrgIcVY2ytYqEu0Tx9A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMxNztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/cc51d7b903437bf6121413744e4d5f9c","width":960,"height":317},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/KNiQacYzFkCPV_ar39faIQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD03OTI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/cc51d7b903437bf6121413744e4d5f9c","width":1200,"height":396}},"lazy":false},{"type":"text","content":"Ordinary shares now trade across the NYSE, LSE and STO under a harmonized global listing structure","length":98,"tagName":"p","attribs":{}},{"type":"text","content":"WILMINGTON, Del., February 02, 2026--(BUSINESS WIRE)--AstraZeneca today begins trading its ordinary shares on the New York Stock Exchange (NYSE) for the first time, enabling more US investors to participate in the Company’s strong growth. With this change the trading of AstraZeneca ordinary shares is now aligned across the NYSE, the London Stock Exchange (LSE) and Nasdaq Stockholm (STO) under a harmonized listing structure.","length":427,"tagName":"p"},{"type":"text","content":"Michel Demaré, Chair, AstraZeneca, said: "Today marks the start of an exciting new period for AstraZeneca, one which we believe gives broader access to the largest capital market in the world. This will allow even more investors to participate in AstraZeneca’s future. Our harmonized listing across New York, London and Stockholm reflects strong shareholder support for our growth strategy and positions AstraZeneca to deliver more innovative medicines to more patients around the world."","length":498,"tagName":"p"},{"type":"text","content":"Lynn Martin, President, NYSE Group said: "Today we are proud to welcome AstraZeneca to the NYSE, where it joins a community of groundbreakers and industry leaders. Through its listing on the world’s largest and most liquid capital market, the company is well-positioned to expand its global investor base and accelerate its commitment to delivering innovation to patients and the wider biopharmaceutical industry."...